Dr Reddy’s launches Amlodipine Besylate and Benazepril Hydrochloride capsules

07 Jul 2011 Evaluate

Dr Reddy’s Laboratories has launched Amlodipine Besylate and Benazepril Hydrochloride capsules (5 mg/40 mg and 10 mg/40 mg), a bioequivalent generic version of LOTREL capsules in the US market on July 05, 2011, following the approval by the United States Food & Drug Administration (USFDA) of Dr Reddy’s Abbreviated New Drug Application (ANDA) for the said capsules.

The LOTREL brand has U.S sales of approximately $290 million for the most recent twelve months ending March 2011 according to IMS Health. Dr Reddy’s Amlodipine Besylate and Benazepril Hydrochloride capsules are available in 100 count bottles.

Recently, Dr Reddy’s Laboratories had launched Levofloxacin tablets 250mg, 500mg, and 750mg, a bioequivalent generic version of Levaquin tablets in the US market on June 20, 2011, following the approval by the USFDA of the company’s ANDA for Levofloxacin tablets.

Dr. Reddys Lab Share Price

1342.45 16.45 (1.24%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.